Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 2Ovarian Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 744Paclitaxel 743Bevacizumab 715Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Fitness Trackers × Clear all
NCT03364673 2023-10-13

Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer

Dana-Farber Cancer Institute

Phase NA Completed
29 enrolled 16 charts
Gynecologic

Motor Activity, Ovarian Neoplasms

NCT01778127 2015-05-21

A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase NA Completed
105 enrolled 33 charts

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡